Currently, there are 215.21M common shares owned by the public and among those 190.67M shares have been available to trade.
The company’s stock has a 5-day price change of -23.06% and 54.79% over the past three months. HIMS shares are trading 113.34% year to date (YTD), with the 12-month market performance up to 104.34% higher. It has a 12-month low price of $13.47 and touched a high of $72.98 over the same period. HIMS has an average intraday trading volume of 44.10 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -8.45%, 1.21%, and 44.99% respectively.
Institutional ownership of Hims & Hers Health Inc (NYSE: HIMS) shares accounts for 70.31% of the company’s 215.21M shares outstanding.
It has a market capitalization of $11.06B and a beta (3y monthly) value of 2.04. The stock’s trailing 12-month PE ratio is 71.92, while the earnings-per-share (ttm) stands at $0.69. The company has a PEG of 2.08 and a Quick Ratio of 1.32 with the debt-to-equity ratio at 0.12. Price movements for the stock have been influenced by the stock’s volatility, which stands at 12.14% over the week and 9.41% over the month.
Earnings per share for the fiscal year are expected to increase by 27.49%, and 43.43% over the next financial year. EPS should grow at an annualized rate of 34.58% over the next five years, compared to 17.22% over the past 5-year period.
Needham coverage for the Hims & Hers Health Inc (HIMS) stock in a research note released on June 04, 2025 offered a Buy rating with a price target of $65. TD Cowen was of a view on April 29, 2025 that the stock is Hold, while Morgan Stanley gave the stock Equal-Weight rating on February 18, 2025, issuing a price target of $42- $60. Citigroup on their part issued Sell rating on January 10, 2025.
